Anebulo Pharmaceuticals, Inc.
0.0M
$35.48M
-5.74
$-0.25
No price alerts set. Add an alert to get notified!
-5.74
4.18
$-0.25
-72.78%
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
CLNN
Clene Inc.
|
$6.29 | 5.54% | -2.37 | $62.00M | -1.23 |
|
COYA
Coya Therapeutics, Inc.
|
$4.46 | -0.89% | -3.52 | $74.61M | 0.00 |
|
ESLA
Estrella Immunopharma, Inc.
|
$1.22 | 4.27% | -3.35 | $51.28M | 0.00 |
|
IMMX
Immix Biopharma, Inc.
|
$11.40 | 5.84% | -15.45 | $604.71M | 0.13 |
|
MGNX
MacroGenics, Inc.
|
$3.12 | 0.48% | -2.64 | $197.98M | 1.92 |
|
OKYO
OKYO Pharma Limited
|
$1.61 | -4.17% | -13.06 | $61.39M | -0.05 |
|
PLRX
Pliant Therapeutics, Inc.
|
$1.35 | 2.67% | -0.55 | $82.65M | 0.16 |
|
TLSA
Tiziana Life Sciences Ltd
|
$1.34 | -0.37% | -4.08 | $79.33M | 0.01 |
|
WHWK
Whitehawk Therapeutics Inc
|
$3.94 | 1.03% | -13.24 | $185.95M | 0.00 |
|
ZNTL
Zentalis Pharmaceuticals, Inc.
|
$2.73 | 0.83% | -1.32 | $197.43M | 0.15 |
* Peer stocks are selected based on market capitalization and sector
$3.42
$0.30
$0.00
0.00%
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
